中國玻璃(03300.HK)附屬與建材國際訂立工程合同
中國玻璃(03300.HK)公布,旗下間接非全資附屬公司陝西中玻與建材國際工程集團訂立陝西工程合同。據此,陝西中玻委聘建材國際工程集團就陝西中玻之浮法玻璃生產線的冷修及改造進行設計、採購及安裝工程。有關設計及規劃冷修及改造項目的合同價為198萬元人民幣(下同),及採購及安裝冷修及改造項目的系統、設備及材料的合同價為8,900萬元。
此外,間接全資附屬公司江蘇蘇華達與建材國際工程集團訂立江蘇工程合同,江蘇蘇華達委聘建材國際工程集團就江蘇蘇華達建立新高檔汽車玻璃生產線進行設備及材料採購及安裝工程。有關建立新高檔汽車玻璃生產線的設備及材料採購及安裝工程的合同價為2.86億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.